TB REACH promotes innovative and new ways of detecting and treating TB cases. Our grantees are implementing a number of different approaches and one is the instruction of new diagnostic technology such as Xpert MTB/RIF. Not only are TB REACH grantees using Xpert MTB/RIF on a large scale, but they are using it in different ways, with novel ideas that bring the technology closer to the point of care and directly benefit TB patients.
As part of the support for TB case finding activities, through a Global Drug Facility mechanism, TB REACH has procured 265 GeneXpert machines and more than 500,000 Xpert MTB/RIF cartridges making it the largest single source procurement mechanisms for of the new technology for multicounty initiatives. In addition, 25 machines and just over 100,000 Xpert MTB/RIF cartridges have been committed for wave 4 and wave 3 continuation funding projects.
If your project would like assistance with the procurement of Xpert machines and test cartridges, please use the Xpert MTB/RIF Order Form link to download the document and send it to us.